Q: I was recently informed that providers use cellular-based tissue products to treat ulcers when a patient fails to respond to more conservative treatment options. What constitutes a failed response to treatment and how would this be documented?
Medical Oncology Hematology Consultants, in Newark, Delaware, recently released a notifcation about a data breach that exposed the information of 8,591 patients and occurred around June 7–8, 2018.
Q: What information does HIPAA allow to be shared on a health insurance user portal if multiple family members are on the same policy? Should all individuals on the policy have separate user accounts?
The National Association of Healthcare Revenue Integrity (NAHRI) is pleased to announce Revenue Integrity Week, a national week of recognition for revenue integrity professionals, to be held June 3–7. This year’s theme is Scale New Heights: Elevate Your Profession and Career.
CMS modified its proposal to expand prior authorization and step therapy to protected classes of drugs for Part D and Medicare Advantage beneficiaries, according to a final rule released May 16.
Researchers at the Regenstrief Institute and Indiana University have developed a new tool for providers to track and potentially identify the early onset of serious underlying issues relevant for multiple chronic conditions that may otherwise go undetected.
CMS finalized a rule on May 7 aimed at streamlining the Medicare appeals process by removing the signature requirement for appeal requests of Parts A and B claims and Part D prescription drug coverage determinations.
According to a recent press release, the Department of Justice unsealed an indictment of two Chinese nationals for a hacking incident that resulted in one of the largest health data breaches of all time.
